Protease Inhibitors
Reports outline protease inhibitors study results from Kyushu University, Department of Pharmacy
Published in Hospital Law Weekly, May 1st, 2008
"GM (0.5 -5.0 mM) decreased cell viability in a dose-dependent manner and caused cell injury, whilst nafamostat mesilate (NM), another serine protease inhibitor, or mesilate itself had no effect on cell viability. zVAD-fmk, a pancaspase inhibitor, or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-05-01)
More Articles from Hospital Law Weekly
- Adaptis
Adaptis Promotes Roya Rezai to Chief Compliance Officer - American Medical Association, Advocacy Update, April 14, 2008)
Physician Hospitals of America Denounces 'Farm Bill' Plan to Sell Out Seniors and Physicians to Pay for Agribusiness Subsidies - California Nurses Association/National Nurses Organizing Committee
Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC - California Nurses Association/NNOC
RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors - Cancer
Tenet and the University of Southern California Reach Tentative Agreement Regarding USC University Hospital and USC Norris Cancer Hospital - Committee to Reduce Infection Deaths
April 16th Congressional Hearing on Hospital Infections - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
